JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B1820 Primaquine Diphosphate

Summary: antimalarial agent,blocks protein synthesis

insoluble in EtOH; ≥18.85 mg/mL
A1684 Aprepitant

Target: Substance P/NK1 Receptor

Summary: Substance P (SP) inhibitor

≥26.72 mg/mL
A5786 Natamycin

Summary: Antifungal macrolide polyene

insoluble in EtOH; insoluble in H2O; ≥16.43 mg/mL
A5790 Cidofovir

Target: CMV

Summary: Anti-CMV drug;inhibitor of viral DNA syntheis

insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL
A8311 Maraviroc
2 Citation

Target: CCR

Summary: Selective CCR5 antagonist,antiretroviral agent

≥25.7 mg/mL
A8458 Lamivudine

Target: HBV Proteases

Summary: Nucleoside analog reverse transcriptase inhibitor

≥10.5 mg/mL
B1119 Efavirenz

Target: HIV-1 reverse transcriptase

Summary: Reverse transcriptase inhibitor

insoluble in H2O; ≥15.55 mg/mL
B2097 Ganciclovir

Target: CMV

Summary: Antiviral drug for CMV infections

insoluble in ETOH; ≥25.6 mg/mL
B2143 Tacrolimus (FK506)
2 Citation

Target: Peptidylprolyl isomerases

Summary: Macrolide calcineurin inhibitor,immunosuppressant

≥26.6 mg/mL
B2032 SRPIN340

Target: SRPK1

Summary: Selective SRPK1 inhibitor

insoluble in H2O; ≥10.9 mg/mL